EDESA BIOTECH, INC. Other Comprehensive Income (Loss), Net of Tax
EDESA BIOTECH, INC. (EDSA) reported Other Comprehensive Income (Loss), Net of Tax of -$1.87 million for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-10.
Discontinued › Income Statement
us-gaap:OtherComprehensiveIncomeLossNetOfTax · last filed 2024-05-10
- EDESA BIOTECH, INC. other comprehensive income (loss), net of tax for the quarter ending 2024-03-31 was -$1.87M.
- EDESA BIOTECH, INC. other comprehensive income (loss), net of tax for the quarter ending 2023-12-31 was -$1.68M.
- EDESA BIOTECH, INC. other comprehensive income (loss), net of tax for the quarter ending 2023-03-31 was -$2.33M.
- EDESA BIOTECH, INC. other comprehensive income (loss), net of tax for the quarter ending 2022-12-31 was -$2.36M.
- EDESA BIOTECH, INC. other comprehensive income (loss), net of tax for fiscal 2022 was -$17.56M.
- EDESA BIOTECH, INC. other comprehensive income (loss), net of tax for fiscal 2021 was -$13.26M.
| Period end | Other Comprehensive Income (Loss), Net of Tax 3 month | Other Comprehensive Income (Loss), Net of Tax 6 month | Other Comprehensive Income (Loss), Net of Tax 12 month |
|---|---|---|---|
| 2024-03-31 | -$1.87M 10-Q · filed 2024-05-10 | -$3.55M 10-Q · filed 2024-05-10 | |
| 2023-12-31 | -$1.68M 10-Q · filed 2024-02-09 | ||
| 2023-03-31 | -$2.33M 10-Q · filed 2024-05-10 | -$4.69M 10-Q · filed 2024-05-10 | |
| 2022-12-31 | -$2.36M 10-Q · filed 2024-02-09 | ||
| 2022-09-30 | -$17.56M 10-K · filed 2022-12-16 | ||
| 2021-09-30 | -$13.26M 10-K · filed 2022-12-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B |